GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Aarti Drugs Ltd

Aarti Drugs Q2 FY27 Consolidated Profit Rises 83.27% to Rs. 8,277 lakhs

RESULTS ▲ Positive Development LOW RISK
📅 Filed on BSE: 03 Nov 2026, 07:08 PM IST  ·  BSE ID: 5cf97caa-7634-430a-bde0-f0cd67a6b366
View Original BSE Filing (PDF)
💡
In Simple Terms
Aarti Drugs reported a significant 83.27% rise in consolidated net profit to Rs. 8,277 lakhs for the recent quarter.
🤖 AI Summary
  • Consolidated Profit for Q2 FY27 was Rs. 8,277 lakhs, an 83.27% increase from Q2 FY26.
  • Consolidated Revenue from Operations for Q2 FY27 totaled Rs. 82,624 lakhs.
  • Total Consolidated Income for the quarter ended September 30, 2026, reached Rs. 82,713 lakhs.
  • Half-year consolidated Profit for the period ended September 30, 2026, stood at Rs. 13,290 lakhs.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Consolidated Revenue from operations (Q2 FY27)
82,624 lakhs
Consolidated Total Income (Q2 FY27)
82,713 lakhs
Consolidated Profit for the Quarter (Q2 FY27)
8,277 lakhs
83.27%
Consolidated Profit for the Half Year (H1 FY27)
13,290 lakhs
34.07%
Consolidated Basic EPS (Q2 FY27)
9.07 Rs.
83.27%
🏢 How This Affects the Company
📈
Business Impact
The increase in revenue from operations to Rs. 82,624 lakhs in Q2 FY27 indicates sustained business activity in pharmaceuticals.
💰
Financial Impact
The substantial 83.27% rise in consolidated profit for Q2 FY27 to Rs. 8,277 lakhs impacts the company's earnings and profitability metrics.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required by shareholders based on this financial results filing.
👤
Who Is Affected
All shareholders are affected by the reported financial performance, which shows an 83.27% increase in consolidated net profit for Q2 FY27.
🔍
Management Signal
The financial results indicate management's focus on profitability and revenue growth across operations.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Q3 FY27 financial results — check for sustained profit and revenue growth.
Updates on segment performance — assess continued strength in pharmaceuticals.
Board meetings for potential future corporate actions or strategic announcements.
LOW RISK The filing reports strong financial performance with no immediate risks indicated.
💡 Investor Takeaway
Aarti Drugs reported consolidated net profit of Rs. 8,277 lakhs for Q2 FY27, an 83.27% increase from Rs. 4,516 lakhs in Q2 FY26. Consolidated revenue from operations for Q2 FY27 was Rs. 82,624 lakhs.
⚖️ Strengths & Concerns

✅ Positives

  • Consolidated Profit for Q2 FY27 increased 83.27% to Rs. 8,277 lakhs compared to Rs. 4,516 lakhs in Q2 FY26.
  • Consolidated Revenue from Operations grew to Rs. 82,624 lakhs in Q2 FY27 from Rs. 65,279 lakhs in Q2 FY26.
📅 Company Track Record
Aarti Drugs' Q2 FY27 consolidated profit surged 83.27% to Rs. 8,277 lakhs. This follows Q1 FY27 where consolidated revenue was Rs. 703.6 Crs, and PAT was Rs. 50.1 Crs, with PAT down 7% QoQ.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What was Aarti Drugs' consolidated net profit for Q2 FY27?
Aarti Drugs reported a consolidated net profit of Rs. 8,277 lakhs for the quarter ended September 30, 2026 (Q2 FY27).
How did Aarti Drugs' Q2 FY27 consolidated profit compare to the previous year?
The consolidated profit for Q2 FY27 increased by 83.27% to Rs. 8,277 lakhs, compared to Rs. 4,516 lakhs in Q2 FY26.
What was Aarti Drugs' consolidated revenue from operations in Q2 FY27?
Consolidated revenue from operations for Aarti Drugs in Q2 FY27 was Rs. 82,624 lakhs.
What is Aarti Drugs' consolidated profit for the half year ended September 30, 2026?
The consolidated profit for the half year ended September 30, 2026, was Rs. 13,290 lakhs.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.